BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28674079)

  • 1. Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.
    Duex JE; Owens C; Chauca-Diaz A; Dancik GM; Vanderlinden LA; Ghosh D; Leivo MZ; Hansel DE; Theodorescu D
    Cancer Res; 2017 Sep; 77(18):4858-4867. PubMed ID: 28674079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis.
    Agarwal N; Dancik GM; Goodspeed A; Costello JC; Owens C; Duex JE; Theodorescu D
    Cancer Res; 2016 Sep; 76(17):5175-85. PubMed ID: 27312530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.
    Overdevest JB; Thomas S; Kristiansen G; Hansel DE; Smith SC; Theodorescu D
    Cancer Res; 2011 Jun; 71(11):3802-11. PubMed ID: 21482678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
    Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
    Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
    Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
    BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling.
    Wu CT; Lin WY; Chen WC; Chen MF
    Ann Surg Oncol; 2018 Nov; 25(12):3518-3526. PubMed ID: 30128900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of CD24: association with invasiveness in urothelial carcinoma of the bladder.
    Choi YL; Lee SH; Kwon GY; Park CK; Han JJ; Choi JS; Choi HY; Kim SH; Shin YK
    Arch Pathol Lab Med; 2007 Feb; 131(2):275-81. PubMed ID: 17284113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nkx2.8 Inhibits Epithelial-Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of
    Yu C; Liu Z; Chen Q; Li Y; Jiang L; Zhang Z; Zhou F
    Cancer Res; 2018 Mar; 78(5):1241-1252. PubMed ID: 29311157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD24
    Zhou Z; Li Y; Kuang M; Wang X; Jia Q; Cao J; Hu J; Wu S; Wang Z; Xiao J
    EBioMedicine; 2020 Jan; 51():102598. PubMed ID: 31901872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer.
    Ooki A; VandenBussche CJ; Kates M; Hahn NM; Matoso A; McConkey DJ; Bivalacqua TJ; Hoque MO
    Br J Cancer; 2018 Oct; 119(8):961-970. PubMed ID: 30327565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer.
    Mokkapati S; Porten SP; Narayan VM; Lim AH; Jayaratna IS; Roth B; Cheng T; Navai N; Wszolek M; Melquist J; Manyam G; Choi W; Broom B; Pretzsch S; Czerniak B; McConkey DJ; Dinney CPN
    Mol Cancer Res; 2020 Jun; 18(6):811-821. PubMed ID: 32122956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of GATA6 expression promotes lymphatic metastasis in bladder cancer.
    Wang C; Liu Q; Huang M; Zhou Q; Zhang X; Zhang J; Xie R; Yu Y; Chen S; Fan J; Chen X
    FASEB J; 2020 Apr; 34(4):5754-5766. PubMed ID: 32103545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
    Hurt EM; Kawasaki BT; Klarmann GJ; Thomas SB; Farrar WL
    Br J Cancer; 2008 Feb; 98(4):756-65. PubMed ID: 18268494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated.
    Overdevest JB; Knubel KH; Duex JE; Thomas S; Nitz MD; Harding MA; Smith SC; Frierson HF; Conaway M; Theodorescu D
    Proc Natl Acad Sci U S A; 2012 Dec; 109(51):E3588-96. PubMed ID: 23012401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.
    Zhong Y; Shen S; Zhou Y; Mao F; Guan J; Lin Y; Xu Y; Sun Q
    Med Oncol; 2014 Mar; 31(3):864. PubMed ID: 24519209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD24 Overexpression Related to Lymph Node Invasion and Poor Prognosis of Colorectal Cancer.
    Wang JL; Guo CR; Su WY; Chen YX; Xu J; Fang JY
    Clin Lab; 2018 Apr; 64(4):497-505. PubMed ID: 29739071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer.
    Smith SC; Oxford G; Wu Z; Nitz MD; Conaway M; Frierson HF; Hampton G; Theodorescu D
    Cancer Res; 2006 Feb; 66(4):1917-22. PubMed ID: 16488989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.
    Karikari IO; Gilchrist CL; Jing L; Alcorta DA; Chen J; Richardson WJ; Gabr MA; Bell RD; Kelley MJ; Bagley CA; Setton LA
    J Neurosurg Spine; 2014 Sep; 21(3):386-93. PubMed ID: 24905390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD24 expression is a poor prognostic marker in endometrial carcinoma.
    Karahan N; Güney M; Oral B; Kapucuoglu N; Mungan T
    Eur J Gynaecol Oncol; 2006; 27(5):500-4. PubMed ID: 17139987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.